{"id":"https://openalex.org/W2172084436","doi":"https://doi.org/10.1517/14740338.7.2.107","title":"The role of earlyin vivotoxicity testing in drug discovery toxicology","display_name":"The role of earlyin vivotoxicity testing in drug discovery toxicology","alternate_titles":[],"publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W2172084436","doi":"https://doi.org/10.1517/14740338.7.2.107","mag":"2172084436","pmid":"https://pubmed.ncbi.nlm.nih.gov/18324874"},"language":"en","primary_location":{"id":"doi:10.1517/14740338.7.2.107","doi":"https://doi.org/10.1517/14740338.7.2.107","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14740338.7.2.107","pdf_url":null,"source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2172084436"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014385139","display_name":"Mark R. Fielden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark R Fielden","raw_affiliation_strings":["Roche Palo Alto LLC, Discovery and Investigative Safety, 3431 Hillview Avenue, Palo Alto, CA 94304, USA +1 650 855 5136; +1 650 855 5588; mark.fielden@roche.com","Roche Palo Alto LLC, Discovery and Investigative Safety, 3431 Hillview Avenue, Palo Alto, CA 94304, USA +1 650 855 5136"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, Discovery and Investigative Safety, 3431 Hillview Avenue, Palo Alto, CA 94304, USA +1 650 855 5136; +1 650 855 5588; mark.fielden@roche.com","institution_ids":[]},{"raw_affiliation_string":"Roche Palo Alto LLC, Discovery and Investigative Safety, 3431 Hillview Avenue, Palo Alto, CA 94304, USA +1 650 855 5136","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077350810","display_name":"Kyle L. Kolaja","orcid":"https://orcid.org/0000-0003-1520-9037","observed_orcids":["https://orcid.org/0000-0003-1520-9037"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kyle L Kolaja","raw_affiliation_strings":["Roche Palo Alto LLC, Discovery and Investigative Safety, 3431 Hillview Avenue, Palo Alto, CA 94304, USA +1 650 855 5136; +1 650 855 5588; mark.fielden@roche.com","Roche Palo Alto LLC, Discovery and Investigative Safety, 3431 Hillview Avenue, Palo Alto, CA 94304, USA +1 650 855 5136"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Palo Alto LLC, Discovery and Investigative Safety, 3431 Hillview Avenue, Palo Alto, CA 94304, USA +1 650 855 5136; +1 650 855 5588; mark.fielden@roche.com","institution_ids":[]},{"raw_affiliation_string":"Roche Palo Alto LLC, Discovery and Investigative Safety, 3431 Hillview Avenue, Palo Alto, CA 94304, USA +1 650 855 5136","institution_ids":["https://openalex.org/I129302853"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I129302853"],"apc_list":null,"apc_paid":null,"fwci":7.8399,"has_fulltext":false,"cited_by_count":98,"citation_normalized_percentile":{"value":0.97515424,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"7","issue":"2","first_page":"107","last_page":"110"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attrition","display_name":"attrition","score":0.6340000033378601},{"id":"https://openalex.org/keywords/preclinical-safety-evaluation","display_name":"preclinical safety","score":0.6589999794960022},{"id":"https://openalex.org/keywords/predictive-toxicology","display_name":"predictive toxicology","score":0.6129999756813049},{"id":"https://openalex.org/keywords/in-vitro-in-vivo-extrapolation","display_name":"in vitro-in vivo extrapolation","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.733729898929596},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5511356592178345},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.5284796953201294},{"id":"https://openalex.org/C40993552","wikidata":"https://www.wikidata.org/wiki/Q514654","display_name":"Gold standard (test)","level":2,"score":0.48498106002807617},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.48070698976516724},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.47598448395729065},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4740141034126282},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4633368253707886},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45410215854644775},{"id":"https://openalex.org/C2780553607","wikidata":"https://www.wikidata.org/wiki/Q684868","display_name":"Attrition","level":2,"score":0.423380970954895},{"id":"https://openalex.org/C33070731","wikidata":"https://www.wikidata.org/wiki/Q7218","display_name":"Toxicology","level":1,"score":0.38866767287254333},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.3495984673500061},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3369736075401306},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.24040433764457703},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.1670597493648529},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.12414011359214783},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12258249521255493},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0},{"id":"https://openalex.org/C199343813","wikidata":"https://www.wikidata.org/wiki/Q12128","display_name":"Dentistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018675","descriptor_name":"Toxicity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023421","descriptor_name":"Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1517/14740338.7.2.107","doi":"https://doi.org/10.1517/14740338.7.2.107","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14740338.7.2.107","pdf_url":null,"source":{"id":"https://openalex.org/S20709540","display_name":"Expert Opinion on Drug Safety","issn_l":"1474-0338","issn":["1474-0338","1744-764X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Drug Safety","raw_type":"journal-article"},{"id":"pmid:18324874","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18324874","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on drug safety","raw_type":"Editorial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1970191094","https://openalex.org/W1993428183","https://openalex.org/W1998028009","https://openalex.org/W2007194208","https://openalex.org/W2011909468","https://openalex.org/W2022868257","https://openalex.org/W2084845010","https://openalex.org/W2091863056","https://openalex.org/W2104209550","https://openalex.org/W2105317622","https://openalex.org/W2113061167","https://openalex.org/W2121175754","https://openalex.org/W2126739473","https://openalex.org/W2133566477","https://openalex.org/W2402390758","https://openalex.org/W2437428173"],"related_works":["https://openalex.org/W2768897220","https://openalex.org/W4391079588","https://openalex.org/W2145702061","https://openalex.org/W2343532630","https://openalex.org/W2089377837","https://openalex.org/W1975970021","https://openalex.org/W2789537144","https://openalex.org/W2218204925","https://openalex.org/W2078508871","https://openalex.org/W2084845010"],"abstract_inverted_index":{"The":[0,37],"cost":[1],"impact":[2],"of":[3,6,39,64,139],"late-stage":[4],"failures":[5],"drug":[7,40,168],"candidates":[8],"has":[9],"motivated":[10],"the":[11,82,117,161],"pharmaceutical":[12],"industry":[13],"to":[14,45,58,61,88,128,145,160,165],"develop,":[15],"validate,":[16],"and":[17,32,78,101,109,148,152,156],"implement":[18],"a":[19],"more":[20],"proactive":[21],"testing":[22,127],"paradigm,":[23],"including":[24],"an":[25],"emphasis":[26],"on":[27,92],"conducting":[28],"predictive":[29],"in":[30,33,69,73,81,86,99,102,111,125],"vitro":[31,103],"vivo":[34,112,126],"studies":[35,77],"earlier.":[36],"goal":[38],"discovery":[41,131],"toxicology":[42],"is":[43,51],"not":[44],"reduce":[46],"or":[47],"eliminate":[48],"attrition,":[49],"as":[50,54],"often":[52],"mis-stated":[53],"such,":[55],"but":[56],"rather":[57],"reprioritize":[59],"efforts":[60],"shift":[62,72],"attrition":[63,74],"future":[65],"failing":[66],"molecules":[67,93],"upstream":[68],"discovery.":[70],"This":[71],"requires":[75],"additional":[76],"investment":[79],"earlier":[80],"candidate":[83],"evaluation":[84],"process":[85],"order":[87],"avoid":[89],"spending":[90],"resources":[91],"with":[94],"soon-to-be-discovered":[95],"development-limiting":[96],"liabilities.":[97],"While":[98],"silico":[100],"models":[104,115],"will":[105],"continually":[106],"be":[107,154],"developed":[108],"refined,":[110],"preclinical":[113],"safety":[114],"remain":[116],"gold":[118],"standard":[119],"for":[120],"assessing":[121],"human":[122],"risk.":[123],"For":[124],"influence":[129],"early":[130],"effectively,":[132],"it":[133],"must:":[134],"i)":[135],"require":[136],"low":[137],"amounts":[138],"compound;":[140],"ii)":[141],"provide":[142,157],"rapid":[143],"results":[144,158],"drive":[146],"decision-making":[147],"medicinal":[149],"chemistry":[150],"efforts;":[151],"iii)":[153],"flexible":[155],"relevant":[159],"development":[162],"plan":[163],"tailored":[164],"each":[166],"target,":[167],"class,":[169],"and/or":[170],"indication.":[171]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2172084436","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
